Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh J Field

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Antiviral Chemistry & Chemotherapy|August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnavirusesErik De Clercq, Hugh J Field
Antiviral Chemistry & Chemotherapy|July 31, 2009
From print to web: a landmark transition after 20 years of publishingHugh J Field, Melissa N Galea
Antiviral Chemistry & Chemotherapy|March 16, 2007
High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1Subhajit Biswas, Mihaiela Swift, Hugh J Field
The Journal of Antimicrobial Chemotherapy|June 7, 2007
Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1Subhajit Biswas, Christopher Smith, Hugh J Field
Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
Antiviral agents for herpes simplex virusR Anthony Vere Hodge, Hugh J Field
British Medical Bulletin|April 19, 2013
Recent developments in anti-herpesvirus drugsHugh J Field, R Anthony Vere Hodge
Future Medicinal Chemistry|December 24, 2013
Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infectionsSubhajit Biswas, Soumi Sukla, Hugh J Field
Journal of Virological Methods|July 4, 2008
Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compoundsIslam T M Hussein, Hugh J Field
Antiviral Research|December 19, 2006
The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1Subhajit Biswas, Lyn Jennens, Hugh J Field
Antiviral Chemistry & Chemotherapy|October 30, 2003
Antiviral activity of CTC-8 against herpes simplex virus (HSV-1) in cell culture: evidence for a selective antiviral effect via a cellular mechanismTim Fitzmaurice, David R Harper, Hugh J Field
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Antiviral Chemistry & Chemotherapy|August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnavirusesErik De Clercq, Hugh J Field
Antiviral Chemistry & Chemotherapy|July 31, 2009
From print to web: a landmark transition after 20 years of publishingHugh J Field, Melissa N Galea
Antiviral Chemistry & Chemotherapy|March 16, 2007
High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1Subhajit Biswas, Mihaiela Swift, Hugh J Field
The Journal of Antimicrobial Chemotherapy|June 7, 2007
Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1Subhajit Biswas, Christopher Smith, Hugh J Field
Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
Antiviral agents for herpes simplex virusR Anthony Vere Hodge, Hugh J Field
British Medical Bulletin|April 19, 2013
Recent developments in anti-herpesvirus drugsHugh J Field, R Anthony Vere Hodge
Future Medicinal Chemistry|December 24, 2013
Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infectionsSubhajit Biswas, Soumi Sukla, Hugh J Field
Journal of Virological Methods|July 4, 2008
Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compoundsIslam T M Hussein, Hugh J Field
Antiviral Research|December 19, 2006
The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1Subhajit Biswas, Lyn Jennens, Hugh J Field
Antiviral Chemistry & Chemotherapy|October 30, 2003
Antiviral activity of CTC-8 against herpes simplex virus (HSV-1) in cell culture: evidence for a selective antiviral effect via a cellular mechanismTim Fitzmaurice, David R Harper, Hugh J Field
Pageof 4